Home » Newsletters » BioWorld Science

BioWorld Science

April 9, 2002

View Archived Issues

DB-289 enters phase II trial for PCP in HIV/AIDS patients

Third phase III trial under way for INS-365 Ophthalmic in dry eye

Promising profile reported at AACR meeting for novel histone deacetylase inhibitor CG-1521

LAQ-824: a potential new antitumor agent acting via inhibition of histone deacetylase

Novel RXR agonist characterized at ACS meeting by GSK

Flt-3 kinase inhibitors and potential for treatment of AML discussed in Orlando by Millennium

Favorable pharmacokinetic profile seen for novel tyrosine kinase inhibitor CHIR-200131

Orally active VEGF receptor tyrosine kinase-selective agent presented at AACR meeting

Independent review and long-term follow-up of phase II Orathecin study

ACS news: Abbott describes discovery of new series of PTP1B inhibitors

Potent, selective, nonpeptide PTP1B inhibitors discovered in Novo Nordisk/Ontogen joint effort

Adherex and AstraZeneca extend Exherin collaboration agreement

European Commission designates E21R orphan drug in JMML

IAVI-sponsored AIDS vaccines enter phase II

Gliatech receives grant for selective GlyT1 inhibitor development

Collateral updates achievements of 2001

Preclinical data discussed this week support clinical trials with thioplatin

WX-G250 and WX-G250RIT designated orphan drugs for renal cell carcinoma in E.U.

Inhibitors of uPA with favorable PK properties described in patent literature

New vascular damaging agents in development at Angiogene Pharmaceuticals

Neurogen patents new series for CNS disorders

Potent and selective uPA inhibitors designed by Corvas scientists

Streptomyces strain discovered to produce new antitumor compounds

Antiherpesvirus agents jointly prepared by Pfizer and JT

Japan Tobacco patents analgesic thiazole compounds

Gene-based therapy EG-009 designated orphan drug for high-grade glioma

FDA approves SecreFlo for diagnosis of pancreatic dysfunction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...